BioPartner Center Leiden Company Profile

10:24 EDT 21st June 2018 | BioPortfolio

BioPartner Center Leiden was in april 2003 het eerste BioPartner Center in Nederland dat startende ondernemers mocht verwelkomen. Het Center is gevestigd in een gebouw van de Universiteit Leiden (Sylviuslaboratorium) op het BioScience Park in Leiden. In 2004 heeft het BioPartner Center haar eigen entree geopend in dit pand. Momenteel beslaat het center ca. 1.100 m2. BioPartner Center Leiden biedt startende ondernemers in de Life Sciences naast flexibele kantoor- en laboratoriumfaciliteiten in samenwerking met Competence Centre Life Sciences ook management onderteuning en een uitgebreid netwerk van contacten. Bedrijven in het BioPartner Center Leiden profiteren niet alleen van het dienstenaanbod van het Center zelf, maar door de onderlinge contacten met collega-huurders onstaat een waardevol bedrijvennetwerk


Wassenaarseweg 72
United States of America


Phone: 071 5276340
Fax: 071 5276343

News Articles [478 Associated News Articles listed on BioPortfolio]

Leiden researcher makes new breakthrough in nanotherapy

Nanoparticles that transport medicines to a specific part of the human body are usually broken down in the liver prematurely. Jeroen Bussmann from Leiden University has discovered a new method to prev...

First Rounders: Jeffery Leiden

The First Rounders podcast with Jeff can be found here. A Boston Globe article on Leiden taking the CEO position at Vertex is here and one from Xconomy is here. Read the Forbes piece on Vertex’s suc...

MRI-detected erosions do not specify RA

Debbie M. BoetersThe characteristics of MRI-detected joint erosions that are specific to rheumatoid arthritis appear infrequently, and may overlap with erosion scores among asymptomatic individuals an...

Vertex Pharmaceuticals' (VRTX) CEO Jeff Leiden on Q4 2017 Results - Earnings Call Transcript

Broad antibody profile associated with improved initial RA treatment response

Among patients with rheumatoid arthritis, a broad baseline autoantibody profile correlated with a better response to early treatment, according to findings published in Arthritis Research and Therapy....

Berry Appleman Leiden LLP Lawyers Assist With Local Immigrant Workshops

"Working for one of the largest corporate immigration firms in the world gives us the experience and the ability to help out our neighbors," Malm Read more...

Valley Forge Military College to Rename Center for Advancement of Security Studies as H.R. ...

The new H.R. McMaster Center for Security Studies, or simply The McMaster Center, will transition from a virtual coordinating center housing faculty expertise to one Read more...

Berry Appleman Leiden Advances Innovative Digital Immigration Services Platform with ...

"In an increasingly complex global economy, an effective immigration strategy is a competitive necessity for every company that does business internationally," said Jeremy Fudge, Read more...

Drugs and Medications [0 Results]


PubMed Articles [548 Associated PubMed Articles listed on BioPortfolio]

Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.

Cancer and factor V Leiden mutation are both risk factors for venous thromboembolism (VTE). Cancer critically increases the thrombotic risk whereas Factor V Leiden is the most common pro-thrombotic mu...

Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.

 This article estimates the interaction between types of combined hormonal contraception (CHC) and factor V Leiden (FVL) mutation on the risk of venous thrombosis event (VTE).

The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.

Aim To investigate association of factor V Leiden, prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women. Methods A total of 60 women with two o...

First Rounders podcast: Jeffrey Leiden.

A Case Report of Recurrent Severe Peripartum Cardiomyopathy Complicated by Factor V Leiden and Multiple Endocrine Neoplasia Type 1: A Management Conundrum.

Cardiovascular disease is the leading cause of peripartum death in the United States during pregnancy. The presence of concomitant diagnoses may complicate or conflict with the management of the prima...

Clinical Trials [1620 Associated Clinical Trials listed on BioPortfolio]

Factor V Leiden Mutation and Implantation Failure

The purpose of this study is to determine whether inherited thrombophilias (tendency toward blood clotting) increase the risk of failure of the embryo to implant in IVF. The specific cond...

Prevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising Enzymes

CYPTAM-BRUT 3 is a prospective, multicentric study in Belgium within the CYPTAM study of the Leiden University Medical Center (NTR1509) including postmenopausal women receiving tamoxifen f...

Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy

Chronic central serous chorioretinopathy (cCSC) is a relatively frequently occurring eye disease that is often diagnosed in patients in the professionally active age range. In this disease...

Establishing a Controlled Human Hookworm Infection Model at Leiden University Medical Center

Four healthy hookworm-naive volunteers will be exposed to 50 L3 Necator americanus larvae once and will retain infection for up to 2 years.

The Netherlands Epidemiology of Obesity Study

The Netherlands Epidemiology of Obesity (NEO) study is a population-based cohort study in 6671 men and women aged 45 to 65 years, with an oversampling of individuals with a BMI of 27 kg/m2...

Companies [1372 Associated Companies listed on BioPortfolio]

BioPartner Center Leiden

BioPartner Center Leiden was in april 2003 het eerste BioPartner Center in Nederland dat startende ondernemers mocht verwelkomen. Het Center is gevestigd in een gebouw van de Universiteit Leiden (Sylv...


There are a number of UK companies and research organisations who have indicated that they are potentially interested in entering into collaborative arrangements with partners overseas. On this site y...

Ichor Medical Systems

Ichor Medical Systems’ TriGrid™ Delivery System is the first integrated and fully automated system for electroporation-mediated DNA administration in humans. Ichor, a pr...

DPS Engeneering

Formed in 1974, DPS is now a leading Engineering and Project Management Company in the Pharmaceutical Industry. We serve a broad range of clients from our 3 offices - Cork, Dublin and Leiden. DPS is f...


Crucell discovers and develops fully human biopharmaceuticals that utilize the immune system to combat disease. Crucell’s proprietary technology platforms, MAbstract™ , AdVac™ and PER.C6™ , en...

More Information about "BioPartner Center Leiden" on BioPortfolio

We have published hundreds of BioPartner Center Leiden news stories on BioPortfolio along with dozens of BioPartner Center Leiden Clinical Trials and PubMed Articles about BioPartner Center Leiden for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioPartner Center Leiden Companies in our database. You can also find out about relevant BioPartner Center Leiden Drugs and Medications on this site too.

Quick Search


Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Corporate Database Quicklinks

Searches Linking to this Company Record